Clinical Trial Update: Imlifidase Prior to Kidney Transplant in Highly Sensitised Children [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating imlifidase to desensitize highly sensitized pediatric kidney transplant candidates is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Imlifidase (imlifidase)

Snippet

Sponsor: Hansa Biopharma AB | Conditions: Kidney Transplantation in Highly Sensitized Patients | Phase 2 | Status: RECRUITING